Contributor Disclosures for Pityriasis Alba
Role Name Disclosure Details
Author Mohsin Ali, MBBS, FRCP, MRCP, MRCPI, Consulting Staff, Department of Dermatology, Amersham General Hospital, UK Nothing to discloseDetails
Coauthor Bassam Zeina, MD, PhD, Consulting Staff, Department of Dermatology, Milton Keynes Hospital, United Kingdom Nothing to discloseDetails
Coauthor Sohail Mansoor, MBBS, MSc, Dermatologist and Lead Physician in Dermatologic Surgery, Department of Dermatology, Barnet Hospital, London, UK Nothing to discloseDetails
Medical Editor Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine Abbott Laboratories
Actelion
Amgen
Astellas
Basilea
Boehringer-Ingelheim
Briston-Myers Squibb
Celtic Pharma
Centocor
Cephalon
Chattem
DermiPsor
Doak
DOV
Forward
Galderma
Genentech
Genzyme
GlaxoSmithKline
Graceway
Helix BioMedix
Isotechnika
Ligand
Medicis
Neosil
Novartis
OMP
Pepgen
Pfizer
PharmaDerm
Roche
Stiefel
Teva
UCB
Warner Chilcott
Details
Pharmacy Editor David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic 3M Pharmaceutical
Graceway Pharmaceuticals
Details
Managing Editor Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center Nothing to discloseDetails
CME Editor Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University Nothing to discloseDetails
Chief Editor Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center Nothing to discloseDetails






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Mohsin Ali

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Bassam Zeina

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Sohail Mansoor, Coauthor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Mark G Lebwohl

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Abbott Laboratories
HonorariaConsulting 
Actelion
HonorariaConsulting 
Amgen
HonorariaConsulting 
Astellas
HonorariaConsulting 
Basilea
HonorariaConsulting 
Boehringer-Ingelheim
HonorariaConsulting 
Briston-Myers Squibb
HonorariaConsulting 
Celtic Pharma
HonorariaOther 
Centocor
HonorariaConsulting 
Cephalon
HonorariaConsulting 
Chattem
HonorariaOther 
DermiPsor
HonorariaConsulting 
Doak
HonorariaOther 
DOV
HonorariaConsulting 
Forward
HonorariaConsulting 
Galderma
HonorariaConsulting 
Genentech
HonorariaConsulting 
Genzyme
HonorariaConsulting 
GlaxoSmithKline
HonorariaConsulting 
Graceway
HonorariaConsulting 
Helix BioMedix
HonorariaConsulting 
Isotechnika
HonorariaConsulting 
Ligand
HonorariaOther 
Medicis
HonorariaInvestigator 
Neosil
HonorariaConsulting 
Novartis
HonorariaConsulting 
OMP
HonorariaOther 
Pepgen
HonorariaConsulting 
Pfizer
HonorariaConsulting 
PharmaDerm
HonorariaOther 
Roche
HonorariaConsulting 
Stiefel
HonorariaConsulting 
Teva
HonorariaConsulting 
UCB
HonorariaConsulting 
Warner Chilcott
HonorariaReview panel membership 
Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
David F Butler

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

3M Pharmaceutical
Grant/research fundsOther 
Graceway Pharmaceuticals
Grant/research fundsOther 
Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Christen M Mowad, Managing Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Catherine Quirk

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Dirk M Elston

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication